| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $77.7M | +0.8% | +24.4% |
| Cost of Revenue | $6.5M | — | -24.1% |
| R&D Expense | $7.5M | — | +30.1% |
| SG&A Expense | $22.0M | -49.8% | +8.3% |
| Operating Income | $41.4M | +24.6% | +89.6% |
| Pre-tax Income | $43.9M | — | +80.4% |
| Income Tax | $9.6M | — | +852.2% |
| Net Income | $34.4M | -83.7% | +47.2% |
| EPS (Basic) | $0.26 | -83.8% | +52.9% |
| EPS (Diluted) | $0.25 | -83.7% | +56.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $40.7M | -49.2% | -38.4% |
| Accounts Receivable | $49.2M | +18.6% | +21.9% |
| Inventory | $46.4M | +1.6% | +0.5% |
| Current Assets | $480.2M | -2.4% | +18.4% |
| Total Assets | $724.0M | -3.7% | +43.4% |
| Current Liabilities | $86.6M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $32.6M | — | +2404.6% |
| Investing Cash Flow | -$18.1M | — | -158.3% |
| Financing Cash Flow | -$53.7M | — | -8.8% |
| +26.5% |
| Total Liabilities | $156.4M | -8.2% | +1.1% |
| Stockholders' Equity | $567.6M | -2.4% | +62.1% |